The T-Cell Immunotherapy Market is projected to achieve a valuation of USD 36.2 billion by 2031|DMI Report
The Global T-Cell Immunotherapy market, which was valued at USD 2.9 billion in 2023, is expected to grow significantly, reaching USD 36.2 billion by 2031. This growth represents a compound annual growth rate (CAGR) of 29.3% from 2024 to 2031.
